Climate Change Data Portal
DOI | 10.1126/science.abg9175 |
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection | |
Stamatatos L.; Czartoski J.; Wan Y.-H.; Homad L.J.; Rubin V.; Glantz H.; Neradilek M.; Seydoux E.; Jennewein M.F.; MacCamy A.J.; Feng J.; Mize G.; De Rosa S.C.; Finzi A.; Lemos M.P.; Cohen K.W.; Moodie Z.; McElrath M.J.; McGuire A.T. | |
发表日期 | 2021 |
ISSN | 0036-8075 |
起始页码 | 1413 |
结束页码 | 1418 |
卷号 | 372期号:6549 |
英文摘要 | Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have raised concerns about resistance to neutralizing antibodies elicited by previous infection or vaccination. We examined whether sera from recovered and naïve donors, collected before and after immunizations with existing messenger RNA (mRNA) vaccines, could neutralize the Wuhan-Hu-1 and B.1.351 variants. Prevaccination sera from recovered donors neutralized Wuhan-Hu-1 and sporadically neutralized B.1.351, but a single immunization boosted neutralizing titers against all variants and SARS-CoV-1 by up to 1000-fold. Neutralization was a result of antibodies targeting the receptor binding domain and was not boosted by a second immunization. Immunization of naïve donors also elicited cross-neutralizing responses but at lower titers. Our study highlights the importance of vaccinating both uninfected and previously infected persons to elicit cross-variant neutralizing antibodies. © 2021 American Association for the Advancement of Science. All rights reserved. |
英文关键词 | SARS coronavirus |
语种 | 英语 |
来源期刊 | Science
![]() |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/245590 |
作者单位 | Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States; Department of Global Health, University of Washington, Seattle, WA, United States; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States; Centre de Recherche du CHUM, Montréal, QC, Canada; Département de Microbiologie Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada; Department of Medicine, University of Washington, Seattle, WA, United States |
推荐引用方式 GB/T 7714 | Stamatatos L.,Czartoski J.,Wan Y.-H.,et al. mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection[J],2021,372(6549). |
APA | Stamatatos L..,Czartoski J..,Wan Y.-H..,Homad L.J..,Rubin V..,...&McGuire A.T..(2021).mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.Science,372(6549). |
MLA | Stamatatos L.,et al."mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection".Science 372.6549(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。